Profile data is unavailable for this security.
About the company
Nanorepro AG is a Germany-based company active in the biotechnology sector. The Company is engaged in the research of stem cells, which are used in the medical treatment due to their ability to self-renew and differentiate to a range of specialized cell types. Nanorepro AG gathers samples of patients’ stem cells and stores them for the future use. Its portfolio also comprises OTC rapid diagnostic tests, such as OvuQUICK, an ovulation test for women; GraviQUICK, a pregnancy test; MenoQUICK, a menopause test; VagiQUICK, a vaginal yeast test; GlutenCHECK, a test to detect celiac disease; CholesterinCHECK, a test to measure the level of total cholesterol, HDL and LDL, as well as FertiQUICK, a fertility test for men.
- Revenue in EUR (TTM)13.93m
- Net income in EUR-6.58m
- Incorporated2007
- Employees17.00
- LocationNanoRepro AGUntergasse 8MARBURG AN DER LAHN 35037GermanyDEU
- Phone+49 6 421951449
- Fax+49 6 421951451
- Websitehttps://www.nanorepro.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vidac Pharma Holding PLC | 0.00 | -1.02m | 10.15m | 4.00 | -- | -- | -- | -- | -0.0193 | -0.0193 | 0.00 | -0.0095 | 0.00 | -- | -- | -- | -562.46 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Biofrontera AG | 32.25m | -369.00k | 21.33m | 88.00 | -- | 0.9189 | 50.54 | 0.6614 | -0.0654 | -0.0654 | 6.16 | 3.82 | 1.02 | 1.27 | 42.49 | 366,465.90 | -1.16 | -11.99 | -1.64 | -15.19 | 80.64 | 84.28 | -1.14 | -20.93 | 1.26 | 0.7071 | 0.0525 | -- | 25.30 | 8.85 | 99.16 | -- | 12.20 | -- |
NanoRepro AG | 13.93m | -6.58m | 22.07m | 17.00 | -- | 0.5146 | -- | 1.58 | -0.5328 | -0.5328 | 1.14 | 3.32 | 0.2864 | 1.44 | 1.53 | 733,372.60 | -13.52 | 20.52 | -13.92 | 23.15 | 32.46 | 35.59 | -47.22 | 11.83 | 42.54 | -- | 0.00 | 31.99 | -76.35 | 87.53 | -112.53 | -- | 56.67 | -- |
B.M.P. Pharma Trading AG | 1.64k | 1.57m | 32.80m | 45.00 | 20.90 | -- | 20.89 | 19,998.28 | 0.299 | 0.299 | 0.0003 | -- | -- | -- | -- | 36.44 | -- | 16.68 | -- | 17.58 | -46.34 | 0.2347 | 95,712.20 | 87,097.18 | -- | -493.86 | -- | -- | -96.34 | -61.60 | 75.39 | 43.01 | -- | -- |
MediGene AG | -100.00bn | -100.00bn | 41.41m | 86.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -22.31 | -- | -25.28 | -- | 90.15 | -- | -123.17 | -- | -- | -- | -- | -80.69 | -4.89 | -94.20 | -- | -8.12 | -- |
BRAIN Biotech AG | 55.23m | -8.40m | 60.08m | 311.00 | -- | 2.93 | -- | 1.09 | -0.3843 | -0.3843 | 2.53 | 0.9375 | 0.7778 | -- | -- | 167,351.50 | -11.67 | -10.71 | -15.18 | -14.46 | 56.12 | 56.16 | -15.01 | -17.47 | -- | -2.80 | 0.00 | -- | 11.79 | 14.12 | -25.63 | -- | 14.47 | -- |
Apontis Pharma AG | 36.96m | -9.40m | 76.84m | 177.00 | -- | 2.45 | -- | 2.08 | -1.10 | -1.10 | 4.37 | 3.69 | 0.682 | 3.01 | 15.40 | 208,835.00 | -15.87 | -- | -18.25 | -- | 63.77 | -- | -23.27 | -- | 2.63 | -- | 0.1658 | -- | -33.67 | -- | -520.38 | -- | -- | -- |
4Sc AG | 304.00k | -8.24m | 77.84m | 15.00 | -- | 15.90 | -- | 256.06 | -0.8144 | -0.8144 | 0.0301 | 0.4995 | 0.0236 | -- | 3.68 | 20,266.67 | -63.84 | -39.49 | -77.78 | -42.84 | 68.75 | 92.24 | -2,709.54 | -337.74 | -- | -- | 0.00 | -- | -30.28 | -40.78 | 42.64 | -- | -56.05 | -- |
Cantourage Group SE | -100.00bn | -100.00bn | 86.09m | 2.00 | -- | 1.95 | -- | -- | -- | -- | -- | 3.72 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- |
Haemato AG | 260.81m | 9.61m | 90.42m | 78.00 | 9.23 | 0.5929 | 8.40 | 0.3467 | 1.84 | 1.84 | 50.10 | 28.67 | 1.47 | 9.80 | 12.48 | 3,343,690.00 | 5.41 | 2.01 | 6.45 | 2.70 | 7.56 | 8.42 | 3.68 | 1.21 | 1.66 | -- | 0.0203 | 157.20 | -12.95 | -3.03 | 25.39 | 3.32 | -5.75 | -16.74 |